Abstract
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with severe infections in immunocompromised patients. EBV is also causally linked with several human malignancies. The heterophile antibody test and EBV-specific antibody tests remain the principal means of diagnosis of initial infection in otherwise healthy patients. Enzyme-linked immunosorbent assays have replaced the traditional immunofluorescence assays for EBV-specific antibodies. Several newer molecular diagnostic tests have become available that facilitate accurate monitoring of infection. The role of these tests for patients with uncomplicated infectious mononucleosis is limited, although these tests are being increasingly used to monitor the state and level of EBV replication for severe infections and among immunocompromised patients. Antiviral therapy has a limited, short-term effect on oropharyngeal shedding but has proven ineffective for the clinical manifestations of infectious mononucleosis. Patients with selected complications frequently benefit from short-term corticosteroid therapy.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA: Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 1997, 71:4882–4891.
Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T: Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infection 2000, 2:115–120.
Reichart PA, Langford A, Gelderblom HR, et al.: Oral hairy leukoplakia: observations in 95 cases and review of the literature. J Oral Pathol Med 1989, 18:410–415.
Barberà JA, Hayashi S, Hegele RG, Hogg JC: Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992, 145:940–946.
Miller G, Grogan E, Rowe D, et al.: Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis 1987, 156:26–35.
Latour S, Veillette A: Molecular and immunological basis of Xlinked lymphoproliferative disease. Immunol Rev 2003, 192:212–224.
Fleisher G, Henle W, Henle G, et al.: Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis 1979, 139:553–558.
Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985, 75:1011–1019.
Jenson HB, Ench Y: Epstein-Barr virus. In Manual of Clinical Laboratory Immunology, edn 6. Edited by Rose NR, Hamilton RG, Detrick B. Washington, DC: American Society for Microbiology Press; 2002:615–626. This article reviews diagnostic methods, including complete protocols for serologic diagnostic tests.
Bruu AL, Hjetland R, Holter E, et al.: Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000, 7:451–456. This is a multicenter comparative evaluation of commercially available serologic tests.
de Schryver A, Klein G, Hewetson J, et al.: Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int J Cancer 1974, 13:353–362.
Rocchi G, Felici A, Ragona G, Heinz A: Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 1977, 296:132–134.
Ambinder RF, Mann RB: Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994, 145:239–252. This article reviews molecular diagnostic testing, including Southern blot analysis for clonality and in situ hybridization for EBER.
Diaz-Mitoma F, Preiksaitis JK, Leung WC, Tyrrell DL: DNA-DNA dot hybridization to detect Epstein-Barr virus in throat washings. J Infect Dis 1987, 155:297–303.
Walling DM, Raab-Traub N: Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol 1994, 68:7909–7917.
Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883–889. This is the initial description of the use of Southern blot analysis to define the clonality of EBV infection.
Raab-Traub N, Webster-Cyriaque J: Epstein-Barr virus infection and expression in oral lesions. Oral Dis 1997, 1:(Suppl3):S164-S170.
Niesters HGM, van Esser J, Fries E, et al.: Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000, 38:712–715.
Kimura H, Morita M, Yabuta Y, et al.: Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999, 37:132–136.
Kimura H, Nishikawa K, Hoshino Y, et al.: Monitoring of cellfree viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) 2000, 188:197–202.
van Laar JA, Buysse CM, Vossen AC, et al.: Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. Arch Intern Med 2002, 162:837–839.
Lo YM, Chan LY, Lo KW, et al.: Quantitative analysis of cellfree Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999, 59:1188–1191.
Lo YM, Chan AT, Chan LY, et al.: Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000, 60:6878–6881.
Lo YM: Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring. Ann NY Acad Sci 2001, 945:68–72. This article reviews molecular diagnostic testing, including quantitative PCR.
Pitetti RD, Laus S, Wadowsky RM: Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 2003, 22:736–739.
Ikuta K, Saiga K, Deguchi M, Sairenji T: Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBVseronegative infants with infectious mononucleosis-like symptoms. Virus Genes 2003, 26:165–173.
Berger C, Day P, Meier G, et al.: Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001, 64:505–512.
Campe H, Jaeger G, Abou-Ajram C, et al.: Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease. Pediatr Transplant 2003, 7:46–52.
Leung E, Shenton BK, Jackson G, et al.: Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 2002, 270:259–267. This article reports the development and application of a quantitative PCR assay using TaqMan methodology.
Weiss LM, Movahed LA, Warnke RA, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 1989, 320:502–506.
Pagano JS, Sixbey JW, Lin JC: Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother 1983, 12(Suppl B):113–121.
Andersson J, Britton S, Ernberg I, et al.: Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis 1986, 153:283–290.
Andersson J, Sköldenberg B, Henle W, et al.: Acyclovir treatment in infectious mononucleosis: a clinical and virological study. Infection 1987, 15:S14-S20.
van der Horst C, Joncas J, Ahronheim G, et al.: Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991, 164:788–792.
Tynell E, Aurelius E, Brandell A, et al.: Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996, 174:324–331.
Torre D, Tambini R: Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999, 31:543–547. This is a meta-analysis of the five published studies of acyclovir treatment of infectious mononucleosis.
Scully C, Porter SR, Di Alberti L, et al.: Detection of Epstein-Barr virus in oral scrapes in HIV infection, in hairy leukoplakia, and in healthy non-HIV-infected people. J Oral Pathol Med 1998, 27:480–482.
Resnick L, Herbst JS, Ablashi DV, et al.: Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA 1988, 259:384–388.
Herbst JS, Morgan J, Raab-Traub N, Resnick L: Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol 1989, 21:753–756.
Greenspan D, De Souza YG, Conant MA, et al.: Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia. J Acquir Immune Defic Syndr 1990, 3:571–578.
Walling DM, Flaitz CM, Nichols CM: Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 2003, 188:883–890.
Walling DM, Edmiston SN, Sixbey JW, et al.: Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 1992, 89:6560–6564.
Walling DM, Clark NM, Markovitz DM, et al.: Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 1995, 171:1122–1130.
Wohl DL, Isaacson JE: Airway obstruction in children with infectious mononucleosis. Ear Nose Throat J 1995, 74:630–638.
Radel EG, Schorr JB: Thrombocytopenic purpura with infectious mononucleosis. J Pediatr 1963, 63:46–60.
Steeper TA, Horwitz CA, Moore SB, et al.: Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med 1989, 150:170–173.
Whitelaw F, Brook MG, Kennedy N, Weir WR: Haemolytic anaemia complicating Epstein-Barr virus infection. Br J Clin Pract 1995, 49:212–213.
Waldo RT: Neurologic complications of infectious mononucleosis after steroid therapy. South Med J 1981, 74:1159–1160.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jenson, H.B. Virologic diagnosis, viral monitoring, and treatment of epstein-barr virus infectious mononucleosis. Curr Infect Dis Rep 6, 200–207 (2004). https://doi.org/10.1007/s11908-004-0009-2
Issue Date:
DOI: https://doi.org/10.1007/s11908-004-0009-2